# Self-Reported Side Effects of Semaglutide and Tirzepatide in Online Communities

Preprint · Neil K. R. Sehgal, Jena Shaw Tronieri, Lyle Ungar, Sharath Chandra Guntuku

- Archive id: arxiv:2603.12341
- Published: 2026-03-12
- arXiv: https://arxiv.org/abs/2603.12341
- Citations: 0
- Source URL: https://arxiv.org/abs/2603.12341
- PDF: https://arxiv.org/pdf/2603.12341
- Provenance: arxiv

## Abstract

Social media can reveal patient experiences with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) that extend beyond clinical trial data. We analyzed 410,198 Reddit posts (May 2019-June 2025) mentioning semaglutide or tirzepatide. A total of 67,008 users self-reported using these medications, and 43.5% described at least one side effect. Gastrointestinal symptoms predominated, including nausea (36.9%), fatigue (16.7%), vomiting (16.3%), constipation (15.3%), and diarrhea (12.6%). Notably, reproductive symptoms (e.g., menstrual irregularities) and temperature-related complaints (e.g., chills, hot flashes) emerged as unrecognized potential effects. These findings highlight patient concerns not well captured in current labeling or trials. Large-scale social media analysis can complement traditional pharmacovigilance by detecting emerging safety signals and expanding understanding of the real-world safety profile of GLP-1 RAs.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.